44 /100
MEDIUM RISK
Score updated May 30, 2026

INTS — Intensity Therapeutics, Inc. Dilution Risk Tracker

Track INTS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INTS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
📉 Score Deterioration 40%
• Score rose 24 points recently (worsening)
🔔 Track INTS — Get forecast alerts →

💹 Market Data

Market Cap$11.87M
Shares Outstanding2.70M
Float2.47M
Cash$10.24M
Debt$102.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 49.1% shares (2025Q4 vs prior)
35 institutional holders · 4.42M shares
#1 Rothschild Wealth LLC 991.8K shares
#2 SAPIENT CAPITAL LLC 650.2K shares
#3 VANGUARD GROUP INC 649.1K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest75.3K
Days to Cover2.5
% of Float3.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2023
4 INSIDER TRANSACTION Jan 05, 2026
4 INSIDER TRANSACTION Jan 05, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track INTS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking INTS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for INTS
📊 INTS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 INTS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.